Prediksi Sifat Farmakokinetik, Toksisitas dan Aktivitas Sitotoksik Turunan N-Benzoil-N’-(4-fluorofenil)tiourea sebagai Calon Obat Antikanker melalui Pemodelan Molekul
Abstrak
Designing new drugs can be performed by structural modification that are made by altering substituted groups which will changes the physical chemistry properties, the pharmacokinetics, toxicity, and activity of each compound. These changes can be predicted by in silico tests. This study aims to predict the physicochemistry properties, pharmacokinetic (ADME), toxicity and cytotoxic activity of 23 compounds of N-benzoyl-N’-(4-fluorophenyl)thiourea derivatives as candidate of anticancer drugs. The in silico test is performed by means of a compound dosage that will predict its activity with the target enzyme SIRT1, PDB ID.4I5I. The result of the bonding form of energy are described by the value of Rerank Score (RS), using the Molegro Virtual Docker program. Compounds with small RS values are predicted to have a great activity. The results of in silico test can be concluded that most N-benzoyl-N’-(4-fluorophenyl)thiourea derivatives ahave good pharmacokinetic properties, cause relatively low toxicity and have greater cytotoxic activity than ligand 4I5_601, and the N-(4-phenylazobenzoyl)-N’-(4-fluorophenyl)thiourea compound are predicted to have the greatest cytotoxic activity.
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.